259 related articles for article (PubMed ID: 29237228)
1. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Gerbens LAA; Hamann SAS; Brouwer MWD; Roekevisch E; Leeflang MMG; Spuls PI
Br J Dermatol; 2018 Jun; 178(6):1288-1296. PubMed ID: 29237228
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
[TBL] [Abstract][Full Text] [Related]
3. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT).
Irvine AD; Jones AP; Beattie P; Baron S; Browne F; Ashoor F; O'Neill L; Rosala-Hallas A; Sach T; Spowart C; Taams L; Walker C; Wan M; Webb N; Williamson P; Flohr C;
Br J Dermatol; 2018 Dec; 179(6):1297-1306. PubMed ID: 29727479
[TBL] [Abstract][Full Text] [Related]
5. Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Drucker AM; Ellis AG; Bohdanowicz M; Mashayekhi S; Yiu ZZN; Rochwerg B; Di Giorgio S; Arents BWM; Burton T; Spuls PI; Küster D; Siegels D; Schmitt J; Flohr C
JAMA Dermatol; 2020 Jun; 156(6):659-667. PubMed ID: 32320001
[TBL] [Abstract][Full Text] [Related]
6. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
7. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.
Flohr C; Rosala-Hallas A; Jones AP; Beattie P; Baron S; Browne F; Brown SJ; Gach JE; Greenblatt D; Hearn R; Hilger E; Esdaile B; Cork MJ; Howard E; Lovgren ML; August S; Ashoor F; Williamson PR; McPherson T; O'Kane D; Ravenscroft J; Shaw L; Sinha MD; Spowart C; Taams LS; Thomas BR; Wan M; Sach TH; Irvine AD;
Br J Dermatol; 2023 Nov; 189(6):674-684. PubMed ID: 37722926
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
[TBL] [Abstract][Full Text] [Related]
11. Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients.
Pino Lopez J; Kromer C; Herr R; Schmieder A; Bayerl C; Schaarschmidt ML
Eur J Dermatol; 2021 Apr; 31(2):233-238. PubMed ID: 33871362
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of methotrexate for childhood atopic dermatitis.
Purvis D; Lee M; Agnew K; Birchall N; Dalziel SR
J Paediatr Child Health; 2019 Dec; 55(12):1487-1491. PubMed ID: 31016803
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Meggitt SJ; Gray JC; Reynolds NJ
Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
[TBL] [Abstract][Full Text] [Related]
15. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
16. Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients.
Thomsen SF; Karlsmark T; Clemmensen KK; Graversgaard C; Ibler KS; Jemec GB; Agner T
Br J Dermatol; 2015 Apr; 172(4):1122-4. PubMed ID: 25350702
[No Abstract] [Full Text] [Related]
17. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
Atakan N; Erdem C
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
19. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Garritsen FM; Roekevisch E; van der Schaft J; Deinum J; Spuls PI; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
